39512-59-9 Usage
Uses
Used in Pharmaceutical Industry:
1-Acetyl-N-(2-methoxyethyl)piperidin-4-amine is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structural composition allows it to be a key component in the development of new drugs, particularly in the area of medicinal chemistry.
Used in Material Science:
1-Acetyl-N-(2-methoxyethyl)piperidin-4-amine is used as a building block in the creation of novel materials with specific properties. Its versatility in chemical reactions enables the synthesis of materials with tailored characteristics for various applications in material science.
Used in Synthetic Chemistry:
1-Acetyl-N-(2-methoxyethyl)piperidin-4-amine is used as a reagent in synthetic chemistry for the preparation of complex organic molecules. Its ability to participate in various chemical reactions makes it a valuable tool for the synthesis of a wide range of compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 39512-59-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,9,5,1 and 2 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 39512-59:
(7*3)+(6*9)+(5*5)+(4*1)+(3*2)+(2*5)+(1*9)=129
129 % 10 = 9
So 39512-59-9 is a valid CAS Registry Number.
39512-59-9Relevant academic research and scientific papers
1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS
-
Paragraph 0532-0533, (2019/07/10)
The present invention provides 1H-pyrazolo[4,3-b]pyridines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.
NEW 3-([1,2,4]TRIAZOLO[4,3-A]PYRIDIN-7-YL)BENZAMIDE DERIVATIVES
-
Page/Page column 56-57, (2008/12/07)
This invention is directed to new inhibitors of the p38 mitogen-activated protein kinase having the general formula (I) to processes for their preparation; to pharmaceutical compositions comprising them; and to their use in therapy.
Mono- or disubstituted 1,2,4,oxadiazoles which are substituted by at least 1-N-substituted carbamoyl group
-
, (2008/06/13)
1,2,4-Oxadiazoles having as 3- and 5-substituents a hydrogen atom, an aliphatic, cycloaliphatic, araliphatic, aryl or heterocyclic group, or a carbamoyl group of the formula -- CONR1 R2 where R1 & R2 which can b
